Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
Clinical trial NCT03858166 · TERMINATED
Trial details
- NCT number
- NCT03858166
- Sponsor
- Shandong University
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2020-12-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.